Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2026-04-15 @ 4:04 PM
Study NCT ID:
NCT05891561
Status:
RECRUITING
Last Update Posted:
2024-11-27
First Post:
2023-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer
Sponsor:
Organization: